SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-154636
Filing Date
2024-06-05
Accepted
2024-06-05 06:04:32
Documents
15
Period of Report
2024-06-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d819044d8k.htm   iXBRL 8-K 28665
2 EX-99.1 d819044dex991.htm EX-99.1 56464
6 GRAPHIC g819044g0605010059277.jpg GRAPHIC 2356
  Complete submission text file 0001193125-24-154636.txt   222186

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vir-20240605.xsd EX-101.SCH 2834
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vir-20240605_lab.xml EX-101.LAB 17993
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vir-20240605_pre.xml EX-101.PRE 11251
18 EXTRACTED XBRL INSTANCE DOCUMENT d819044d8k_htm.xml XML 3630
Mailing Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158
Business Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39083 | Film No.: 241020632
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)